Clinical Trial Update: Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) [Phase 3]

View source ↗

Summary

The KESETT trial evaluating ketamine add-on therapy for established status epilepticus is in Phase 3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Virginia | Conditions: Status Epilepticus | Phase 3 | Status: RECRUITING